SDL (SDL) is currently trading at 29.63 per share. Stock prices fluctuate during market hours on NSE and BSE based on demand, company updates, and overall market conditions. Refer to the live price chart above for the most recent price movement.

The company specializes in producing microbiological, immunological, and biochemical diagnostic reagents and related products. It has recently completed an expansion and modernization of its packaging activities in Udhna, which indicates an intention to increase production capacity. The company holds strategic land assets at a prime location, facilitating future industrial expansion. Partnerships with international firms for technical collaboration expand their technological capabilities, particularly in diagnostic testing. New product launches under their brand CRYSTAL reflect innovation and a focus on niche segments like Blood Banks, fostering potential growth.

Over the past 52 weeks, SDL has traded between a low of ₹29.63 and a high of ₹29.64. The 52-week high and low indicate the stock’s price range over the last year and help investors understand its volatility and recent trading levels.

SDL has a market capitalization of approximately N/A. Market capitalization represents the total value of a company’s outstanding shares and helps investors understand its size, stability, and relative risk compared to other listed companies.

SDL’s investment profile depends on its business fundamentals, valuation, and long-term outlook. The stock currently trades at a PE ratio of N/A and operates in the its sector sector. Investors typically assess financial performance, growth prospects, and individual risk tolerance before making investment decisions.

Based on its market capitalization of N/A Cr, SDL is classified as a N/A stock. Large-cap stocks are generally more stable, while mid-cap and small-cap stocks tend to offer higher growth potential along with higher price volatility.

SDL operates in the its sector sector. Sector classification matters because companies in the same sector are often affected by similar economic conditions, regulatory changes, and competitive dynamics, which can influence overall stock performance.

The Price-to-Earnings (PE) ratio of SDL is N/A. The PE ratio compares a company’s share price to its earnings and is commonly used to assess valuation. Comparing the PE ratio with sector peers and historical levels provides better context.

Span Divergent reported a consolidated net loss of ₹1.1882 crore for Q1FY27 (quarter ended June 30, 2026).